NewAmsterdam Pharma Cash Flow Statement (2022-2026) | NAMS

Cash Flow Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -42.02M-47.13M-49.47M-93.77M-39.01M-16.65M48.05M-39.53M-17.36M-72.00M-74.92M-48.44M
Share-based Compensation (Quarter) 7.62M5.56M5.39M6.01M7.92M8.29M8.00M9.41M15.21M15.18M15.01M14.02M18.00M
Gains from Sales and Divestitures (Quarter) 0.14M0.14M0.14M0.14M0.21M
Gains from Investment Securities (Quarter) 11.37M1.60M4.10M4.54M20.18M26.64M17.30M4.42M0.06M29.60M54.60M
Non-cash Items (Quarter) 50.80M6.13M6.89M145.76M297.98M183.78M9.66M10.10M10.08M327.60M
Cash from Operations (Quarter) -31.86M-29.30M-46.98M-33.07M-54.60M-53.98M-12.50M-37.48M-36.47M-37.67M-32.77M-40.88M-30.60M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) -0.51M-0.47M-0.40M-0.02M0.01M
Depreciation & Amortization (CF) (Quarter) 0.01M0.01M0.01M0.01M0.02M0.03M0.05M0.05M0.04M0.06M0.06M0.06M
Change in Working Capital
Change in Account Payables (Quarter) -2.92M4.33M-9.23M12.89M-8.31M-3.35M1.91M-3.20M2.25M-0.39M-2.27M5.32M-0.79M
Change in Accured Expenses (Quarter) 7.00M-5.07M9.34M-5.80M-1.38M0.27M0.40M2.39M-4.95M1.44M0.64M5.32M-10.33M
Investing Activities
Capital Expenditures (Quarter) 0.01M0.01M0.01M0.00M0.39M0.21M0.07M0.00M0.02M0.09M0.04M0.10M0.04M
Change in Acquisitions & Divestments (Quarter) 12.50M24.66M34.40M50.50M51.00M
Cash from Investing Activities (Quarter) -0.01M-0.01M-0.01M-0.00M-0.39M-0.21M-0.07M-62.18M2.85M-159.14M2.51M-21.14M-11.51M
Financing Activities
Other financing activities (Quarter) 0.52M1.59M
Change in Capital Stock
Shares Issued (Quarter) 2.39M6.23M-8.33M8.33M0.44M12.98M-12.92M1.27M0.18M0.00M16.78M12.50M10.41M
Misc.
Cash from Financing Activities (Quarter) 2.39M6.33M0.19M198.18M4.66M0.06M456.61M6.52M3.42M5.89M13.68M11.06M
Exchange Rate Effect (Quarter) 3.06M-0.01M-1.60M5.22M-2.50M-0.91M4.54M-7.94M3.77M8.83M0.22M-0.06M-1.33M
Change in Cash (Quarter) -29.48M-22.98M-46.80M-33.08M143.19M-49.53M-12.52M356.95M-27.09M-193.38M-24.37M-48.33M-31.05M
Free Cash Flow (Quarter) -31.87M-46.98M-33.08M-54.99M-54.19M-12.58M-37.48M-36.48M-37.76M-32.81M-40.98M-30.64M
Net Cash Flow (Quarter) -29.48M-46.80M-33.08M143.19M-49.53M-12.52M356.95M-27.09M-193.38M-24.37M-48.33M-31.05M